Post-licensure monitoring of HPV vaccine in the United States
- 5 July 2010
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 28 (30), 4731-4737
- https://doi.org/10.1016/j.vaccine.2010.02.019
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenThe Lancet, 2009
- Monitoring the impact of vaccines postlicensure: new challenges, new opportunitiesExpert Review of Vaccines, 2008
- Human papillomavirus and cervical cancerThe Lancet, 2007
- Quadrivalent Vaccine against Human Papillomavirus to Prevent Anogenital DiseasesNew England Journal of Medicine, 2007
- Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical LesionsNew England Journal of Medicine, 2007
- Chapter 4: Burden and management of non-cancerous HPV-related conditions: HPV-6/11 diseaseVaccine, 2006
- Chapter 2: The burden of HPV-related cancersVaccine, 2006
- Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccinationVaccine, 2006
- Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic ReviewCancer Epidemiology, Biomarkers & Prevention, 2005
- Practice article. National immunization survey: the methodology of a vaccination surveillance systemPublic Health Reports®, 2000